Efficiency of using Canephron® N in the treatment of children with secondary hyperoxaluria
Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 7
Abstract
Background. The purpose of our work was to study the clinical effectiveness of the application of phytotherapeutic drug Canephron® N for secondary hyperoxaluria in children in combination with diet as compared to the dietary treatment alone. Materials and methods. 46 children aged 6–18 years with secondary hyperoxaluria were examined. Depending on the treatment scheme, patients are divided into groups: the main group (23 children) and the comparison group (23 persons). All children received dietary treatment with the exception of high-oxalic acid foods and sufficient drinking regime. In addition to diet therapy, the patients of the main group were treated with Canephron® N for 3 months. Daily excretion of oxalates, calcium, uric acid, phosphate and calcium/creatinine ratio in the morning urine before treatment and after 3 months of therapy were studied. Results. After 3 months of therapy, there was a decrease in daily excretion of oxalate in urine in both observation groups. The decrease in urinary excretion of oxalate on the background of therapy was more significant in children of the main group than in the comparison group (3.050 ± 0.320 vs. 1.600 ± 0.102, p < 0.001). The incidence of hyperoxaluria on the background of therapy in the main group decreased from 100 to 56.5 % (p < 0.01), in the comparison group it almost did not change (from 100 to 82.6 %, p > 0.05). The incidence of hypercalciuria in both groups did not change. At the same time, the daily excretion of calcium, phosphorus and uric acid in the main group was significantly reduced. In patients of the main group, there was a decrease in the erythrocyturia rate — from 52.2 to 17.4 % (p < 0.01). In patients of the comparison group, this indicator did not change significantly. The level of daily proteinuria before and after the treatment decreased only in children of the main group — from 0.117 g/day to 0.052 g/day (p < 0.02). Conclusions. Using phytotherapeutic drug Canephron® N for three-month therapy of secondary hyperoxaluria in children in combination with dietary treatment is more effective than monotherapy with diet and leads to a 3-time decrease of the oxalate level in urine. Treatment with restriction of high-oxalic acid foods gives the result of not more than 1.6 times. The inclusion of phytotherapeutic drug Canephron® N is accompanied by a 3-fold decrease in the erythrocyturia rate and a reduction of daily proteinuria.
Authors and Affiliations
T. P. Borysova
Keywords
Related Articles
- EP ID EP249210
- DOI 10.22141/2224-0551.12.7.2017.116179
- Views 82
- Downloads 0
Frequency of functional disorders of the biliary tract in children with atopic dermatitis
Background. According to the data of numerous authors, the severity of atopic dermatitis (AD) strongly depends on the functional state of the digestive system. The purpose of the study is to analyze frequency and peculia...
Clinical-Anamnestic Features and Evaluation of Control for Exercise-Induced Bronchial Asthma in Schoolchildren with Xenobiotics Biotransformation Genes Polymorphism
Complex clinical and spirographic investigation of schoolchildren suffering from exercise-induced bronchial asthma was carried out depending on the presence or the absence of genes polymorphism of the enzymes of glutatio...
The effect on the availability of manganese and zinc ions for pathogenic bacteria
Manganese and zinc play a role in the infectious process, wherein a change in the concentration of manganese and zinc can significantly impact the disease course. Bacterial pathogens utilize manganese ions as a protector...
Gilbert’s Syndrome: Terminology, Epidemiology, Genetics, Pathogenesis (Part I)
The aim of the review was the analysis of the literature about the prevalence, etiology, genetics and pathogenesis of Gilbert’s syndrome (GS). The scientific literature regarding GS with the keywords «Gilbert's syndrome»...
Using Recombinant Interferon Alpha-2b in Pediatric Practice
Interferon system is a key element of antiviral defense of the child’s body that etiopathogenetically justifies the use of nasal and rectal formulations of recombinant interferon alfa-2b for the prevention and treatment...